Oncotarget: Both BRCA1-wild type and -mutant triple-negative breast cancers show Bioengineer, 26 Feb 2020 Oncotarget Volume 11 Issue 8 features Figure 8, ‘MLN4924 treatment induces DNA damage by stabilizing CDT1 and accumulates the…